News

Blinatumomab, the first of the BiTE antibody constructs, is indicated to treat adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the

Onychomycosis is a fungal infection of the nail and nail bed that affects around 35 million people in the US. In July, Anacor entered into an exclusive agreement

The company’s French subsidiary TFChem has now moved into the next phase of the agreement with France-based contract research organization (CRO) Biogalenys to carry out the trials. Funding

MIN-202 is being developed by Minerva Neurosciences in collaboration with Janssen Pharmaceutica and Janssen Research & Development. The completion of the IND review will allow Janssen to start

In March this year, NovaDel announced its plans to sell all assets with the intention of liquidating the company and distributing its remaining cash to shareholders. With the

The study demonstrating that topical application of pterostilbene onto mouse skin, prior to UV exposure, prevented several types of UV-mediated damage. Specifically, pterostilbene prevented UV-mediated DNA damage, reddening

This multi-centre, placebo-controlled clinical trial (Protocol TRx-237-005) is aimed at assessing the efficacy of LMTX in people diagnosed with mild Alzheimer’s disease. The study is also evaluating the

Concurrently, the Company announced a new corporate management team and its intention to strategically refocus and rebrand the company as PlasmaTech Biopharmaceuticals, Inc.™, and its plans to pursue

With an ED market that brings in billions annually, it’s not hard to figure out why Plandaí would use its unique and proprietary extraction process to try to